["{\n\"step_by_step_thinking\": \"The relevant documents provided do not mention LB-100 or cisplatin. There is a discussion about MRA-CN, a cyanomorpholino derivative of doxorubicin, and its sensitivity to glutathione metabolism inhibitors. Additionally, there are studies on ovarian carcinoma, including metastatic ovarian carcinoma of large intestinal origin and hereditary ovarian carcinoma. However, none of these documents mention LB-100 or cisplatin.\",\n\"answer_choice\": \"B: no\"\n}"]